Concepedia

Diana Restifo

DR

Statistics

Publications

8

Citations

732

H-Index

8

Active since

2012

Affiliations

Fox Chase Cancer Center(Current)

Kazan Federal University

Georgetown University

Kennedy Krieger Institute

Champions Oncology (United States)

Diana Restifo is an author at Fox Chase Cancer Center specializing in oncology, medicine, and cancer cell signaling.

ORCID

Publications per year

2012–2023

8

Publications

8

Cholesterol Pathway Inhibition Induces TGF-β Signaling to Promote Basal Differentiation in Pancreatic Cancer

Linara Gabitova-Cornell, Aizhan Surumbayeva, Suraj Peri et al. · Cancer Cell · 2020 · 228 citations · Full text

, , +14

Netrin G1 Promotes Pancreatic Tumorigenesis through Cancer-Associated Fibroblast–Driven Nutritional Support and Immunosuppression

Ralph Francescone, Débora B. Vendramini‐Costa, Janusz Franco‐Barraza et al. · Cancer Discovery · 2020 · 208 citations · Full text

, , +17

Endogenous Sterol Metabolites Regulate Growth of EGFR/KRAS-Dependent Tumors via LXR

Linara Gabitova, Diana Restifo, Andrey Gorin et al. · Cell Reports · 2015 · 86 citations · Full text

, , +17

Targeting C4-Demethylating Genes in the Cholesterol Pathway Sensitizes Cancer Cells to EGF Receptor Inhibitors via Increased EGF Receptor Degradation

Anna L. Sukhanova, Andrey Gorin, Ilya G. Serebriiskii et al. · Cancer Discovery · 2012 · 76 citations · Full text

, , +17

Screening of Conditionally Reprogrammed Patient-Derived Carcinoma Cells Identifies ERCC3–MYC Interactions as a Target in Pancreatic Cancer

Natalya Beglyarova, Eugenia Banina, Yan Zhou et al. · Clinical Cancer Research · 2016 · 65 citations · Full text

, , +14

1–5 of 8